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Abstract: Intrahepatic bile duct adenoma (BDA) is a rare benign tumor of the liver that is usually diagnosed
by microscopic examination. Most cases are incidentally discovered during surgery or autopsy. Here, we report
the co-existence of colonic adenocarcinoma and intrahepatic BDA mimicking metastasis in a 62-year-old man.
The patient underwent metastasectomy because of the presence of colonic adenocarcinoma diagnosed at
almost the same time. The diagnosis was benign in frozen sections intraoperatively and total colectomy was
performed during the same operation. BDA should be included in the diseases to be differentiated from hepatic
primary or metastatic tumors.
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Özet: ‹ntrahepatik safra duktus adenomu, genellikle mikroskopik inceleme ile tan› alan, karaci¤erin seyrek
görülen benign bir tümörüdür. Ço¤u olgu operasyon s›ras›nda ya da otopsi ile tesadüfen saptan›r. Burada, 62
yaﬂ›ndaki erkek hastada metastaz› taklit eden safra duktus adenomu ile kolonik adenokarsinom birlikteli¤ini
sunduk. Olguda ayn› zamanda kolonik adenokarsinom olmas› nedeniyle metastazektomi operasyonu yap›ld›.
Frozen kesitlerle intraoperatif olarak benign tan›s› kondu, sonra ayn› operasyonda total kolektomi yap›ld›.
Safra duktus adenomu, karaci¤erin primer ya da metastatik tümörlerinin ay›r›c› tan›s›nda yer almal›d›r.
Anahtar Sözcükler: Safra duktus adenomu, karaci¤er, immünhistokimya

Introduction
Bile duct adenoma (BDA) is a small, well-circumscribed mass composed of small acini
and tubules set in fibrous stroma (1). Most cases reported previously were incidentally
discovered during laparotomy or autopsy (1-4). BDA is also referred to as peribiliary
gland hamartoma, benign cholangioma, or cholangioadenoma (2,5).
Macroscopically, they are well circumscribed but not encapsulated, gray-white or tan,
flat or slightly elevated, subcapsular nodules (4). Nearly 40% of cases were originally
considered either suggestive or diagnostic of adenocarcinoma (primary or metastatic) at
the time of referral in one series, emphasizing the importance of familiarity with this
lesion (6).
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Herein, we report the co-existence of colonic adenocarcinoma and intrahepatic BDA
in a 62-year-old man. The diagnosis of BDA was later established pathologically. These
rare benign lesions should be included in the differential diagnosis of hepatic masses in
addition to metastatic lesions even if the patient has a history of malignancy.
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Case Report
A 62-year-old man was admitted to our hospital with a long history of constipation,
rectal bleeding, and weight loss (about 18 kg per 3 months). He had a past medical
history of hepatitis C, gastritis, and appendectomy performed 40 years before.
Rectoscopy was performed and a vegetative lesion was seen at the level of 40 cm.
Colonic adenocarcinoma was identified by endoscopic biopsy.
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On admission, liver function tests were normal except
for a gamma-glutamyl transpeptidase level of 129 U/l
(normal: 0-50 U/l). His serum albumin, bilirubin, and
coagulation parameters were within normal limits. Serum
tumor markers were higher than normal (carbohydrate
antigen 19-9, 47.92 U/ml, carcinoembriyonic antigen
19.85 ng/ml, carbohydrate antigen 72.4, 9.7 U/ml).
Anemia and a decreased serum ferritin level were found.
Ultrasonography and computed tomography revealed a
well-circumscribed mass 1 cm in diameter in the posterior
segment of the right lobe of the liver (Figure 1). Thus,
the lesion was preoperatively diagnosed as an intrahepatic
metastasis of the colonic adenocarcinoma and he was
considered to have Dukes’ stage D tumor. His family
history was negative for familial colon cancer syndromes.
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cm in diameter was surrounded by liver parenchyma
(Figure 2a, b). A frozen section of the liver mass was
interpreted as consistent with a benign lesion. Then left
total colectomy was performed during the same operation.
After fixation in 10% buffered formalin solution, the
left total colectomy and wedge liver biopsy material were
processed conventionally and paraffin embedded.
Sections, 4-µm thick, were stained with hematoxylin and
eosin.
An endophytic-ulcerative predominantly intramural
tumoral lesion 5 cm in diameter was observed in the
sigmoid colon. Histological examination revealed
moderately differentiated adenocarcinoma with atypical
epithelial cells forming glandular structures exhibiting
great variability in size and configuration (Figure 3). The
tumor was invading all layers of the bowel and extending
into the serosal surface, but no metastasis in regional
lymph nodes was present. Therefore, the tumor was
considered Dukes’ stage B2.

Pathological Findings
Metastasectomy was planned and a wedge liver biopsy
was sent for frozen section. A solitary subcapsular, well
demarcated but nonencapsulated tan nodule measuring 1.1

Figure 1. Abdominopelvic computerized tomography at the time of diagnosis showed a
hypodense lesion (arrows) in the posterior lobe of the right lobe of the liver.

a

b

Figure 2. (a) A wedge liver biopsy demonstrating a solitary subcapsular, well demarcated but
nonencapsulated tan nodule and (b) the same lesion in paraffin block.
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In
addition,
histochemistry
and
immunohistochemistry using the labeled streptavidinbiotin peroxidase complex method were performed. A
standard protocol and commercially available reagent
were used (Dako, Neomarkers). Cytokeratin 7,
cytokeratin 20, factor-VIII, CD-34, and CEA were used.
For some antibodies, the tissue was protease-digested
using proteinase. Negative control slides were run in
parallel. A chromogenic precipitate was obtained through
incubation with AEC (3-amino-9-ethyl-carbazole)
substrate chromogen. After counterstaining with Mayer’s
hematoxylin, the sections were coverslipped.
Figure 3. Moderately differentiated adenocarcinoma with atypical
epithelial cells forming glandular structures exhibiting great
variability in size and configuration in colon. (inset:
demonstrating extension of tumoral cells into serosal
surface) (Hematoxylin-eosin ×200).

The microscopic study of the nodule from the liver
showed an increased number of small, normal appearing
bile ducts lined with a single layer of cuboidal cells and
surrounding fibrotic stroma. The bile ducts had no or
little lumina (Figure 4). The fibrous stroma showed
varying degrees of chronic inflammation and
collagenization.

Mucin positivity was observed in some of the bile duct
lumina (Figure 5a). Enclosed in the lesion were normally
spaced portal tracts. Strong and diffuse immunoreactivity
to cytokeratin (CK) 7 was observed in the BDA (Figure
5b), whereas CK20, factor-8, and CD34 stains were
negative. It also showed cytoplasmic reactivity for CEA.
Peripheral liver parenchyma showed the pathology of
hepatitis C virus infection including cytotoxic degenerative
injury to hepatocytes, sinusoidal cell proliferation,
mononuclear inflammatory cell infiltration in portal
tracts, and focal necrosis, but there was no evidence of
cirrhosis.
The patient had an uneventful recovery, and has been
well for 2 years postoperatively.

Discussion
The incidence of benign hepatic tumors other than
hemangioma is relatively low (4). BDA, previously called
cholangioma or cholangioadenoma, and simply bile duct
adenoma, is one of the benign lesions in the liver (3).
BDAs usually appear as solitary nodules but can also
occur as multiple nodules throughout the liver, with
either lobe of the liver being involved (4) BDAs are usually
located on the surface of the liver and are <10 mm in
diameter (2-4).

Figure 4. Photomicrograph of bile duct adenoma characterized
increased number of small, normal appearing bile ducts lined
with a single layer of cuboidal cells and surrounding fibrotic
stroma. The bile ducts had no or little lumina. (inset: showing
a bile duct with lumen formation) (Hematoxylin-eosin ×400).

Neither familial occurrence nor occurrence in children
is uncommon. No symptoms or signs are attributed to the
lesion (4). In the largest reported series of 152 cases, all
were found during either intra-abdominal surgery or
(103 cases) or autopsy (49 cases), with 89 (58.6%)
males and 63 (41.4%) females (2).
The nature and cell origin of bile duct adenomas have
been a subject of controversy. Some authors suggested
353
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Figure 5. (a) Histochemically mucin positivity was observed in some of the bile duct lumina
(×200 at magnification). (b) Cytokeratin (CK) 7 staining confirmed that these cuboidal
cells forming no or little lumina were indeed bile duct in origin (Streptavidin
peroxidase, AEC chromogen ×100).

that they are reactive processes and a result of
hepatocellular damage that induces inflammation, bile
duct proliferation, and scarring as observed in hepatic
cirrhosis (2). Some think that they arise from the
peribiliary glands and have suggested the term
“peribiliary hamartoma” for this lesion, based on
immunohistochemical findings (5). Others state that
these lesions are true neoplasms. The identification of Kras mutations in a small proportion of cases and
malignant transformation of others supports this view
(7).
It remains unknown whether benign hepatic tumors
are related to alcoholic or viral hepatitis, although cases
of complication with hepatitis C or B or alcoholic
hepatitis, including those found by the authors, have been
reported (4). In our case, hepatitis C virus infection was
detected at the same time, but we do not know if there
is any relationship between them.
Bile duct adenomas are well circumscribed but not
encapsulated, firm, gray-white or tan, subscapular
nodules, although they sometimes appear as subscapular
scars. At microscopic level, one sees a compact network
of ductal structures with a simple tubular appearance or
a more complex tortuous arrangement embedded in a
variable amount of fibrous stroma that may be sclerotic
or edematous and infrequently is calcified or contains
granulomas. The tubular lumina are often very small or
inapparent, indistinguishable on histologic evaluation
from bile ductules. Cystic changes are uncommon (6).
Cells of the tumor are low columnar or cuboidal,
containing light colored transparent cytoplasm. They do
354

not show atypia or mitotic activity (4). Intracytoplasmic
mucin can be found, while cytoplasmic or intraluminal bile
is absent (6). The cuboidal/low columnar lining epithelium
has more cytoplasm and paler nuclei than the interlobular
bile ducts present within portal tracts in the adjacent liver
or trapped within the lesion. Focal clear cell change has
been described in these tumors (8). Inflammatory cells—
particularly lymphocytes, but also neutrophils—may be
noted both within and at the periphery of the lesion.
Lymphocytic aggregates may be conspicuous at the
interface with the adjacent liver (6).
The potential for malignant transformation cannot be
entirely excluded, although it is benign in nature (4).
Cases of malignant transformation have been reported
(4,9). Follow-up of resected bile duct adenomas has
indicated that it has a benign clinical course; however, the
potential for malignant transformation has not been
excluded (4).
Pathological differential diagnosis includes bile duct
hamartoma (if multiple, “von Meyenburg complexes”),
cholangiocarcinoma,
metastatic
tumor
from
adenocarcinoma, reactive bile ductile proliferation,
hepatic abscess, inflammatory pseudotumor, and hepatic
granuloma (3,4,6).
Two types of intrahepatic benign bile duct
proliferations have been characterized: bile duct
hamartomas (von Meyenburg complexes) and bile duct
adenomas (8). Von-Meyenberg complexes or biliary
microhamartomas are collections of irregularly shaped
bile ducts in the liver surrounded by a dense collagenous
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Reactive bile ductile proliferation is typically
encountered in the context of cirrhotic septa or biliary
tract disorders. It is distinguished from BDA based on the
context of the lesion as well as histological features. It
typically has no dense sclerosis, except with collapse, and
has possible bile and frequent finding of periductular
neutrophils. Mild atypia and rare mitoses in broad scars
can be observed (6).

Extremely well differentiated cholangiocarcinomas
have been confused with bile duct adenomas by
pathologists. This diagnostic distinction is further
complicated by the fact that well-differentiated
cholangiocarcinoma may follow a prolonged clinical
course (8). Pathological differentiation from
cholangiocarcinoma with mild cellular atypia is very
difficult (3). Except for Ki-67, immunohistochemical
stains are not useful for distinguishing BDAs from
cholangiocarcinomas (8). Nuclear pleomorphism and
hyperchromasia, prominent nuclei, mitosis, and
vascular/lymphatic invasion are all absent in BDAs,
supporting its distinction from adenocarcinoma (6).
Inflammatory pseudotumor, granuloma, and hepatic
abscess were not considered in our case.

In
our
case,
we
also
considered
hemangioendothelioma in the differential diagnosis, but
the lack of infiltrative margin and lack of intracytoplasmic
lumina containing red blood cells in addition to
immunohistochemical CD34 negativity were helpful for
differentiation.

In summary, recognition of this unusual co-existence
of BDA and gastrointestinal tumors will enable surgeons
to avoid diagnostic confusion with metastatic carcinomas.
This lesion is still confused with metastatic carcinomas by
both surgeons and pathologists during frozen sections
performed in patients with known carcinomas.

stroma. They are typically 0.1 to 0.3 cm in diameter and
are well-circumscribed, unencapsulated lesions that are
recognized most easily when in a subcapsular location.
The ductular structures are often dilated cystically and
contain inspissated bile. They are also frequently
mistaken grossly for metastatic tumors, abscesses, or
granulomas (10).
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